BCRX Sep 2024 1.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:15PM EDT. Market open.
| Previous close | 4.6000 |
| Open | 4.6000 |
| Bid | 3.5000 |
| Ask | 8.0000 |
| Strike | 1.00 |
| Expiry date | 2024-09-20 |
| Day's range | 4.6000 - 4.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
GuruFocus.comInsider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
Helen Thackray, Chief Research & Development Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 14, 2024.
GuruFocus.comDirector Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
On May 13, 2024, Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
GuruFocus.comInsider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.
© 2024 Yahoo. All rights reserved.